Related Experiment Video
Updated: Apr 6, 2026

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
19.8K
[Diversity-oriented synthesis and its application in drug discovery]
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|July 31, 2015
Summary
Diversity-oriented synthesis (DOS) creates diverse small molecules for drug discovery. This review covers key DOS strategies and their application in identifying new biologically active compounds.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
Background:
- Diversity-oriented synthesis (DOS) is crucial for generating molecular collections with varied structures.
- Diverse molecular scaffolds are essential for exploring biological processes and identifying drug candidates.
Purpose of the Study:
- To review common strategies in diversity-oriented synthesis.
- To highlight recent literature examples of DOS applications.
- To present the use of DOS libraries in drug discovery.
Main Methods:
- Discussion of reagent-based and substrate-based approaches.
- Explanation of the build-couple-pair strategy.
- Overview of privileged substructure-based DOS.
Main Results:
- Common DOS strategies are detailed with literature examples.
- The review covers diverse molecular features like appendages, functional groups, stereochemistry, and skeletons.
- Applications of DOS libraries in drug discovery are presented.
Conclusions:
- Diversity-oriented synthesis provides a powerful platform for generating molecular diversity.
- The reviewed strategies enable the creation of compound libraries for biological screening.
- DOS plays a significant role in advancing drug discovery efforts.
Related Concept Videos
Drug Discovery: Overview
13.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.3K
Structure-Activity Relationships and Drug Design
2.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.1K
Pharmacogenomics: Identification of New Drug Targets
86
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
86
Quantitative Aspects of Drug-Receptor Interaction
2.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.2K
Targets for Drug Action: Overview
11.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.5K
Diversity in Cell Signaling Responses
8.7K
The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity.
Graded and Abrupt Responses
Some signaling systems generate...
Graded and Abrupt Responses
Some signaling systems generate...
8.7K

